ZA937827B - Piperazine derivatives - Google Patents
Piperazine derivativesInfo
- Publication number
- ZA937827B ZA937827B ZA937827A ZA937827A ZA937827B ZA 937827 B ZA937827 B ZA 937827B ZA 937827 A ZA937827 A ZA 937827A ZA 937827 A ZA937827 A ZA 937827A ZA 937827 B ZA937827 B ZA 937827B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- date
- piperazine derivatives
- sec
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929223153A GB9223153D0 (en) | 1992-11-05 | 1992-11-05 | Piperazine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA937827B true ZA937827B (en) | 1995-04-21 |
Family
ID=10724559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA937827A ZA937827B (en) | 1992-11-05 | 1993-10-21 | Piperazine derivatives |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5827847A (en:Method) |
| EP (1) | EP0877612B1 (en:Method) |
| JP (1) | JP3238153B2 (en:Method) |
| AT (1) | ATE195422T1 (en:Method) |
| AU (1) | AU682155B2 (en:Method) |
| CA (1) | CA2148593C (en:Method) |
| DE (1) | DE69329252T2 (en:Method) |
| DK (1) | DK0877612T3 (en:Method) |
| ES (1) | ES2149216T3 (en:Method) |
| GB (1) | GB9223153D0 (en:Method) |
| GR (1) | GR3034400T3 (en:Method) |
| HU (1) | HUT72049A (en:Method) |
| LV (1) | LV12734B (en:Method) |
| MX (1) | MX9306879A (en:Method) |
| PT (1) | PT877612E (en:Method) |
| TW (1) | TW252043B (en:Method) |
| WO (1) | WO1994009780A1 (en:Method) |
| ZA (1) | ZA937827B (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710481A1 (en) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Use of flesinoxan for cognition enhancement |
| US6271234B1 (en) * | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
| US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
| GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| HUT54666A (en) * | 1989-04-22 | 1991-03-28 | Wyeth John & Brother Ltd | Process for producing peperazine derivatives and pharmaceutical compositions containing them |
| EP0395313B1 (en) * | 1989-04-22 | 1999-12-15 | American Home Products Corporation | Tertiary alkyl functionalized piperazine derivatives |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
| WO1991011435A2 (en) * | 1990-01-11 | 1991-08-08 | The Upjohn Company | NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS |
| GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
| AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
-
1992
- 1992-11-05 GB GB929223153A patent/GB9223153D0/en active Pending
-
1993
- 1993-10-21 ZA ZA937827A patent/ZA937827B/xx unknown
- 1993-10-25 DK DK93923615T patent/DK0877612T3/da active
- 1993-10-25 JP JP51081394A patent/JP3238153B2/ja not_active Expired - Fee Related
- 1993-10-25 DE DE69329252T patent/DE69329252T2/de not_active Expired - Fee Related
- 1993-10-25 ES ES93923615T patent/ES2149216T3/es not_active Expired - Lifetime
- 1993-10-25 CA CA002148593A patent/CA2148593C/en not_active Expired - Fee Related
- 1993-10-25 EP EP93923615A patent/EP0877612B1/en not_active Expired - Lifetime
- 1993-10-25 HU HU9501290A patent/HUT72049A/hu unknown
- 1993-10-25 PT PT93923615T patent/PT877612E/pt unknown
- 1993-10-25 US US08/428,093 patent/US5827847A/en not_active Expired - Fee Related
- 1993-10-25 WO PCT/GB1993/002197 patent/WO1994009780A1/en not_active Ceased
- 1993-10-25 AU AU53421/94A patent/AU682155B2/en not_active Ceased
- 1993-10-25 AT AT93923615T patent/ATE195422T1/de not_active IP Right Cessation
- 1993-10-26 TW TW082108882A patent/TW252043B/zh active
- 1993-11-04 MX MX9306879A patent/MX9306879A/es not_active IP Right Cessation
-
2000
- 2000-09-13 GR GR20000402090T patent/GR3034400T3/el not_active IP Right Cessation
-
2001
- 2001-07-04 LV LVP-01-102A patent/LV12734B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE195422T1 (de) | 2000-09-15 |
| GB9223153D0 (en) | 1992-12-16 |
| DE69329252D1 (de) | 2000-09-21 |
| DK0877612T3 (da) | 2000-10-09 |
| MX9306879A (es) | 1995-01-31 |
| DE69329252T2 (de) | 2001-03-29 |
| AU5342194A (en) | 1994-05-24 |
| AU682155B2 (en) | 1997-09-25 |
| TW252043B (en:Method) | 1995-07-21 |
| LV12734A (en) | 2001-10-20 |
| HU9501290D0 (en) | 1995-06-28 |
| JPH08502743A (ja) | 1996-03-26 |
| US5827847A (en) | 1998-10-27 |
| PT877612E (pt) | 2000-11-30 |
| EP0877612B1 (en) | 2000-08-16 |
| ES2149216T3 (es) | 2000-11-01 |
| CA2148593A1 (en) | 1994-05-11 |
| JP3238153B2 (ja) | 2001-12-10 |
| GR3034400T3 (en) | 2000-12-29 |
| EP0877612A1 (en) | 1998-11-18 |
| CA2148593C (en) | 2005-12-06 |
| LV12734B (en) | 2002-01-20 |
| WO1994009780A1 (en) | 1994-05-11 |
| HUT72049A (en) | 1996-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123142A0 (en) | The use of adamantan-derivatives for the treatment of the inner ear | |
| GB9300194D0 (en) | Piperazine derivatives | |
| CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
| MY131641A (en) | Indoline derivatives, process of preparation and use | |
| GB9300195D0 (en) | Piperazine derivatives | |
| AU5818394A (en) | Use of prodelphinidines for treating arthrosis | |
| TW281673B (en:Method) | ||
| ZA941739B (en) | Amide derivatives | |
| GB9223153D0 (en) | Piperazine derivatives | |
| AU3386299A (en) | N-aryloxyethylamine derivatives for the treatment of depression | |
| TW251283B (en:Method) | ||
| AU3443593A (en) | 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents | |
| ES8605802A1 (es) | Procedimiento para la fabricacion de nuevos compuestos cina-moicos | |
| GR3034688T3 (en) | Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions | |
| ATE136217T1 (de) | Verwendung von imino-derivaten von etianaldehyd zur herstellung eines arzneimittels zur behandlung des bluthochdrucks | |
| GB9304632D0 (en) | Amide derivatives | |
| DK0691846T3 (da) | Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet | |
| AU5696594A (en) | Triazoloquinazolines for the treatment of diseases of the central vervous system | |
| ES2103232A1 (es) | Nuevos compuestos derivados de 1h-imidazol-2-metanol. |